scholarly article | Q13442814 |
P50 | author | Nabeel Bardeesy | Q30004507 |
Carlos Fernández-del Castillo | Q40930249 | ||
Kevin M Haigis | Q87900780 | ||
Keith D Lillemoe | Q103302432 | ||
P2093 | author name string | David T Ting | |
Andrew L Warshaw | |||
Andrew X Zhu | |||
Lipika Goyal | |||
Vikram Deshpande | |||
Nabeel Bardeesy | |||
Cristina R Ferrone | |||
Aram F Hezel | |||
Ioannis T Konstantinidis | |||
P2860 | cites work | Profiling critical cancer gene mutations in clinical tumor samples | Q21562343 |
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors | Q24535796 | ||
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes | Q28307762 | ||
Pancreatic cancer | Q29616288 | ||
Outcome of treatment for distal bile duct cancer | Q34416917 | ||
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution | Q34578979 | ||
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer | Q34618537 | ||
Distinguishing Pancreatic Carcinoma From Other Periampullary Carcinomas by Analysis of Mutations in the Kirsten-ras Oncogene | Q36784748 | ||
Pancreatic adenocarcinoma: the actual 5-year survivors | Q37008577 | ||
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. | Q37316584 | ||
Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre ra | Q37457763 | ||
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. | Q37474061 | ||
Ki-ras point mutations and proliferation activity in biliary tract carcinomas | Q39999643 | ||
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up | Q45071353 | ||
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? | Q45661541 | ||
High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater. | Q53413496 | ||
High-throughput oncogene mutation profiling in human cancer | Q57693480 | ||
Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis | Q73031231 | ||
Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts | Q73704618 | ||
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience | Q79369906 | ||
P433 | issue | 5 | |
P921 | main subject | bile duct carcinoma | Q11611688 |
P304 | page(s) | 953-959 | |
P577 | publication date | 2016-03-08 | |
P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
P1476 | title | Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma | |
P478 | volume | 20 |
Q49825838 | Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer |
Q39167413 | Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management |
Q38911733 | Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. |
Search more.